In a single-arm phase 2 trial, Jian Zhang, Yanchun Meng &co assess activity & safety of combining dalpiciclib with pyrotinib & endocrine therapy in patients receiving first- or second-line treatment for ER-positive & HER2-positive advanced breast cancer🧪 #BreastCancerAwarenessMonth plos.io/4iu26Xe

Show Post

As part of #BreastCancerAwarenessMonth, we’re showcasing research and perspectives that contribute to improving #breastcancer care, supporting earlier #diagnosis, informing treatment decisions, and advancing equity for patients worldwide🎗️🧪 #MedSky

Show Post

Nice to see the PLOS Medicine editors together in person for their team retreat/workshop! ☀️🙌 @alisonfarrell.bsky.social @acmdc.bsky.social @droutledge.bsky.social @helenlumbard.bsky.social

Show Post

We publish impactful research that transforms global healthcare, prioritizing studies addressing critical health challenges that bridge scientific rigor with real-world impact, connecting researchers, clinicians, and policymakers to advance global health. 🔗 plos.io/4xC4UGk

Show Post

In recognition of #WorldHeartDay, this Editorial by Manpreet Kaur discusses the opportunities and challenges of harnessing #cardiovascular data from smartwatches, which may be a powerful tool in informing equitable and actionable cardiovascular disease research 🫀 🧪 #CVD #MedSky plos.io/4xVyUNB

Show Post